221 related articles for article (PubMed ID: 25526450)
1. Utility of PET/CT in the diagnosis and staging of extranodal natural killer/T-cell lymphoma: a systematic review and meta-analysis.
Zhou X; Lu K; Geng L; Li X; Jiang Y; Wang X
Medicine (Baltimore); 2014 Dec; 93(28):e258. PubMed ID: 25526450
[TBL] [Abstract][Full Text] [Related]
2. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.
Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY
Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis.
Wu LM; Chen FY; Jiang XX; Gu HY; Yin Y; Xu JR
Eur J Radiol; 2012 Feb; 81(2):303-11. PubMed ID: 21145680
[TBL] [Abstract][Full Text] [Related]
4. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
[TBL] [Abstract][Full Text] [Related]
5. [Value of 18F-FDG PET/CT and PET in diagnosing and staging extranodal nasal type natural killer/T-cell lymphoma:A Meta-analysis].
Ji J; Liu XH; She NN; Li L; Zhang XB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 32(24):1876-1882. PubMed ID: 30550130
[No Abstract] [Full Text] [Related]
6. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
[TBL] [Abstract][Full Text] [Related]
7. The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma.
Fujiwara H; Maeda Y; Nawa Y; Yamakura M; Ennishi D; Miyazaki Y; Shinagawa K; Hara M; Matsue K; Tanimoto M
Eur J Haematol; 2011 Aug; 87(2):123-9. PubMed ID: 21557776
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?
Adams HJ; Kwee TC; de Keizer B; Fijnheer R; de Klerk JM; Littooij AS; Nievelstein RA
Ann Oncol; 2014 May; 25(5):921-7. PubMed ID: 24351400
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT may replace bone marrow biopsy for the evaluation of bone marrow involvement in selected mature T- and natural killer-cell lymphomas: A meta-analysis.
Guo L; Wang R; Hou N; Kuang A; Shen G
Eur J Radiol; 2024 Mar; 172():111353. PubMed ID: 38320330
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma.
Adams HJ; Nievelstein RA; Kwee TC
J Comput Assist Tomogr; 2017 Jan; 41(1):98-103. PubMed ID: 27560022
[TBL] [Abstract][Full Text] [Related]
11. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.
Ngeow JYY; Quek RHH; Ng DCE; Hee SW; Tao M; Lim LC; Tan YH; Lim ST
Ann Oncol; 2009 Sep; 20(9):1543-1547. PubMed ID: 19474116
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.
Treglia G; Salsano M; Stefanelli A; Mattoli MV; Giordano A; Bonomo L
Skeletal Radiol; 2012 Mar; 41(3):249-56. PubMed ID: 22072239
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
[TBL] [Abstract][Full Text] [Related]
14. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
Lin CY; Lin CL; Kao CH
Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
[TBL] [Abstract][Full Text] [Related]
15. The utility of FDG-PET for managing patients with malignant lymphoma: analysis of data from a single cancer center.
Imataki O; Tamai Y; Yokoe K; Furukawa T; Kawakami K
Intern Med; 2009; 48(17):1509-13. PubMed ID: 19721294
[TBL] [Abstract][Full Text] [Related]
16. Comparison of
Geng H; Li J; Zhang W
Heliyon; 2024 Jan; 10(1):e23922. PubMed ID: 38226231
[TBL] [Abstract][Full Text] [Related]
17. [The Application Value of True Whole-body PET/CT Scanning Protocol in Patients of Extranodal NK/T Cell Lymphoma].
Li FL; Su MG; Shi DZ; Liang FL; Li L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):245-251. PubMed ID: 32220195
[TBL] [Abstract][Full Text] [Related]
18. The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma.
Karantanis D; Subramaniam RM; Peller PJ; Lowe VJ; Durski JM; Collins DA; Georgiou E; Ansell SM; Wiseman GA
Clin Lymphoma Myeloma; 2008 Apr; 8(2):94-9. PubMed ID: 18501102
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma.
Ding JJ; Chen YL; Zhou SH; Zhao K
J Int Med Res; 2018 Dec; 46(12):4920-4929. PubMed ID: 30328364
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
